A role for IL-4 in immunologically mediated enteropathy
- 1 January 1995
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 99 (1), 65-69
- https://doi.org/10.1111/j.1365-2249.1995.tb03473.x
Abstract
SUMMARY: A number of clinical enteropathies are associated with a local cell-mediated immune (CMI) response, and experimental evidence indicates that cytokines are responsible for the intestinal pathology. We show here that depletion of IL-4 using MoAb or a soluble form of the IL-4 receptor (IL-4R) prevents the jejunal manifestations of a proliferative form of murine graft-versus-host reaction (GVHR) characterized by crypt hyperplasia and recruitment of intraepithelial lymphocytes (IEL). Depletion of IL-4 did not prevent the appearance of villus atrophy in a destructive model of GVHR, and had no effect on any indices of systemic immunity. These results indicate that IL-4 may play a selective role in mediating proliferative aspects of intestinal immunopathology, and suggest that this cytokine may provide a useful target for immunotherapy.Keywords
This publication has 27 references indexed in Scilit:
- Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cellsImmunology Today, 1994
- Disruption of the murine IL-4 gene blocks Th2 cytokine responsesNature, 1993
- Effects of in vivo administration of interferon (IFN)-γ, anti-IFN-γ, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host diseaseClinical Immunology and Immunopathology, 1992
- Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.The Journal of Experimental Medicine, 1992
- Hyper IgE in stimulatory graft- versus-host disease: role of interleukin-4Clinical and Experimental Immunology, 1991
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestineClinical and Experimental Immunology, 1990
- Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.Gut, 1989
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987
- AUGMENTATION OF INTESTINAL AND PERIPHERAL NATURAL KILLER CELL ACTIVITY DURING THE GRAFT-VERSUS-HOST REACTION IN MICETransplantation, 1983